Literature DB >> 15726885

The stability studies and in vitro hepatic microsomal metabolism of some alpha-phenyl-N-substituted nitrones in rats.

Gülen Bulut1, Mehmet Oktav, Mert Ulgen.   

Abstract

Nitrones are a very important class of synthetic chemicals as synthetic intermediates, antioxidant agents, and metabolic oxidation products of secondary amines and imines used drug, food, cosmetic and printing industry. In the present study, the stability experiments and in vitro metabolism studies using rat microsomal preparations fortified with NADPH were carried out using three different alpha-phenyl-N-substituted nitrones ie alpha-phenyl-N-tert-butylnitrone (PTBN), alpha-(2,6-dichlorophenyl)-N-phenylnitrone (DCPPN) and alpha-phenyl-N-adamantanylnitrone (PADN). The separation of these compounds from the potential degradation, isomerization and metabolic products were performed using a reverse phase HPLC system with a diodearray uv detection. Following stability experiments at 37 degrees C using methanolic nitrone solutions, it was observed that PTBN produced trace amounts of benzaldehyde and the corresponding amide. DCPPN also produced trace amounts of amide. After 12 hours, the amount of the amide significantly increased. PADN produced trace amount of benzaldehyde but not any amide. The proposed compounds were incubated with rat microsomal preparations fortified with NADPH, extracted into dichloromethane (DCM) and finally evaporated under nitrogen in the dark conditions. PTBN was metabolized into corresponding amide whereas DCPPN and PADN did not. With all of the substrates, the corresponding aldehydes are observed with both test and control tubes using denaturated microsomes and without co-factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15726885     DOI: 10.1007/BF03190606

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  10 in total

1.  The in vitro hepatic microsomal metabolism of N-benzyladamantanamine in rats.

Authors:  F Yilmaz; M Ulgen; J W Gorrod
Journal:  Drug Metabol Drug Interact       Date:  1999

2.  Preparation of microsomes with calcium.

Authors:  J B Schenkman; D L Cinti
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

3.  Evaluation of the effects of alpha-phenyl-N-tert-butyl nitrone pretreatment on the neurobehavioral effects of methamphetamine.

Authors:  T Kita; Y Matsunari; T Saraya; K Shimada; K O'Hara; K Kubo; G C Wagner; T Nakashima
Journal:  Life Sci       Date:  2000-08-18       Impact factor: 5.037

4.  Metabolic and chemical studies on alpha,N-diarylnitrones.

Authors:  M Ulgen; J W Gorrod
Journal:  Drug Metabol Drug Interact       Date:  1994

5.  In vitro and in vivo assessment of the irritation potential of different spin traps in human skin.

Authors:  J Fuchs; N Groth; T Herrling
Journal:  Toxicology       Date:  2000-10-26       Impact factor: 4.221

6.  Synthesis of a new family of glycolipidic nitrones as potential antioxidant drugs for neurodegenerative disorders.

Authors:  Grégory Durand; Ange Polidori; Jean-Pierre Salles; Bernard Pucci
Journal:  Bioorg Med Chem Lett       Date:  2003-03-10       Impact factor: 2.823

7.  Intravenous pharmacokinetics and metabolism of the reactive oxygen scavenger alpha-phenyl-N-tert-butyl nitrone (PBN) in the cynomolgus monkey.

Authors:  Mary E Lame; Amit S Kalgutkar; Michael LaFontaine
Journal:  Drug Metabol Drug Interact       Date:  2004

8.  Chemical and metabolic studies on N-benzyl-tert-butylamine and its potential metabolites.

Authors:  M Ulgen; F Yilmaz; S Unsalan; J W Gorrod
Journal:  Drug Metabol Drug Interact       Date:  1995

9.  Structure-activity relationships in the formation of amides from substituted N-benzylanilines.

Authors:  M Ulgen; J W Gorrod; D Barlow
Journal:  Xenobiotica       Date:  1994-08       Impact factor: 1.908

10.  Studies on the in vitro hepatic microsomal formation of amides during the metabolism of certain secondary and tertiary benzylic amines.

Authors:  M Ulgen; J W Gorrod
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2000 Apr-Jun       Impact factor: 2.569

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.